The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Open accessAbstract
Here we use the clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas9 endonuclease complexed with dual-RNAs to introduce precise mutations in the genomes of Streptococcus pneumoniae and Escherichia coli. The approach relies on dual-RNA:Cas9-directed cleavage at the targeted genomic site to kill unmutated cells and circumvents the need for selectable markers or counter-selection systems. We reprogram dual-RNA:Cas9 specificity by changing the sequence of short CRISPR RNA (crRNA) to make single- and multinucleotide changes carried on editing templates. Simultaneous use of two crRNAs enables multiplex mutagenesis. In S. pneumoniae, nearly 100% of cells that were recovered using our approach contained the desired mutation, and in E. coli, 65% that were recovered contained the mutation, when the approach was used in combination with recombineering. We exhaustively analyze dual-RNA:Cas9 target requirements to define the range of targetable sequences and show strategies for editing sites that do not meet these requirements, suggesting the versatility of this technique for bacterial genome engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As an example, the most common Cas9 system, SpCas9, recognises NGG motifs and therefore only sequences adjacent to that motif can be targeted [60].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [60]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR systems might be an alternative or a tool to use together with conventional antibiotics, either by disabling antibiotic-resistance genes or by developing toxicity in bacteria through the cleavage of crucial domains of their genome, exerting a bactericidal effect [60].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [60]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In early 2013, Jiang et al. used the CRISPR-Cas9 system to induce targeted mutations (insertions, deletions, and single-nucleotide substitutions) in the genome of Streptococcus pneumoniae and E. coli strains [60].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [60]
In the citing paper
“The type II CRISPR/Cas9 system has been exploited for high-efficiency gene editing in model microorganisms such as E. coli (Jiang et al., 2015), S. cerevisiae (DiCarlo et al., 2013), and Streptococcus pneumoniae (Jiang et al., 2013).”
From Gas Fermentation—A Flexible Platform for Commercial Scale Production of Low-Carbon-Fuels and Chemicals from Waste and Renewable Feedstocks (2016) · cites this paper as Jiang et al., 2013
In the citing paper
“Collectively, these studies indicate that although each base within the 20 nt guide sequence contributes to overall specificity”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [93]
In the citing paper
“multiple mismatches between the guide RNA and its complementary target DNA sequence can be tolerated depending on the quantity, position, and base identity of mismatches [87,90,91,93], all of which contribute to potential off-target activity.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationEnzymatic assembly of DNA molecules up to several hundred kilobases
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., & Smith, H. O. (2009) · Nature Methods · doi:10.1038/nmeth.1318 · Cited by 10,088
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,007
Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus
Fuller, K. K., Chen, S., Loros, J. J., & Dunlap, J. C. (2015) · Eukaryotic Cell · doi:10.1128/ec.00107-15 · Cited by 244
Xue, C., Zhao, J., Chen, L., Yang, S., & Bai, F. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.01.007 · Cited by 243
Targeted mutagenesis in chicken using CRISPR/Cas9 system
Oishi, I., Yoshii, K., Miyahara, D., KAGAMI, H., & Tagami, T. (2016) · Scientific Reports · doi:10.1038/srep23980 · Cited by 246
Biosensor-based engineering of biosynthetic pathways
Rogers, J. K., Taylor, N. D., & Church, G. M. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.03.005 · Cited by 234
Chen, W., Zhang, Y. P., Zhang, Y., Pi, Y., Gu, T., Song, L., Wang, Y., & Ji, Q. (2018) · iScience · doi:10.1016/j.isci.2018.07.024 · Cited by 238
Kim, H. K., Kim, Y., Lee, S., Min, S., Bae, J. Y., Choi, J. W., Park, J., Jung, D., Yoon, S., & Kim, S. (2019) · Science Advances · doi:10.1126/sciadv.aax9249 · Cited by 238
Integrated approaches in microbial degradation of plastics
Jaiswal, S., Sharma, B., & Shukla, P. (2019) · Environmental Technology & Innovation · doi:10.1016/j.eti.2019.100567 · Cited by 243
Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9
Qin, P., Parlak, M., Kuscu, C., Bandaria, J. N., Mir, M., Szlachta, K. A., Singh, R., Darzacq, X., Yıldız, A., & Adli, M. (2017) · Nature Communications · doi:10.1038/ncomms14725 · Cited by 238
Zhang, J., Zong, W., Hong, W., Zhang, Z.-T., & Wang, Y. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.03.007 · Cited by 241
CRISPR-Cas9 for the genome engineering of cyanobacteria and succinate production
Li, H., Shen, C. R., Huang, C.-H., Sung, L., Wu, M., & Hu, Y. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.09.006 · Cited by 235
Piwowarek, K., Lipińska, E., Hać‐Szymańczuk, E., Kieliszek, M., & Ścibisz, I. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8616-7 · Cited by 258
PAM-less plant genome editing using a CRISPR–SpRY toolbox
Ren, Q., Sretenovic, S., Liu, S., Tang, X. D., Huang, L., He, Y., Liu, L., Guo, Y., Zhong, Z., Liu, G., et al. (2021) · Nature Plants · doi:10.1038/s41477-020-00827-4 · Cited by 244
Shen, C., Que, Z., Xia, Y., Tang, N., Li, D., He, R., & Cao, M. (2017) · Journal of Plant Biology · doi:10.1007/s12374-016-0400-1 · Cited by 234
Mustafa, M. I., & Makhawi, A. M. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00745-20 · Cited by 246
RetractedWendt, K. E., Ungerer, J., Cobb, R. E., Zhao, H., & Pakrasi, H. B. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0514-7 · Cited by 232
Single Cas9 nickase induced generation of NRAMP1 knockin cattle with reduced off-target effects
Gao, Y., Wu, H., Wang, Y., Liu, X., Chen, L., Li, Q., Cui, C., Liu, X., Zhang, J., & Zhang, Y. (2017) · Genome biology · doi:10.1186/s13059-016-1144-4 · Cited by 246
The New State of the Art: Cas9 for Gene Activation and Repression
Russa, M. F. L., & Qi, L. S. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00512-15 · Cited by 241
CRMAGE: CRISPR Optimized MAGE Recombineering
Ronda, C., Pedersen, L. E., Sommer, M. O. A., & Nielsen, A. T. (2016) · Scientific Reports · doi:10.1038/srep19452 · Cited by 228
CRISPR/Cas9-coupled recombineering for metabolic engineering of Corynebacterium glutamicum
Cho, J. S., Choi, K. R., Prabowo, C. P. S., Shin, J. H., Yang, D., Jang, J., & Lee, S. Y. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.06.010 · Cited by 224
Cell-Type-Specific CRISPR/Cas9 Delivery by Biomimetic Metal Organic Frameworks
Alyami, M., Alsaiari, S. K., Li, Y., Qutub, S., Aleisa, F. A., Sougrat, R., Merzaban, J. S., & Khashab, N. M. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b11638 · Cited by 229
A CRISPR view of developmentPreprint
Harrison, M. M., Jenkins, B., O’Connor-Giles, K. M., & Wildonger, J. (2014) · Genes & Development · doi:10.1101/gad.248252.114 · Cited by 234
Targeted mutagenesis using CRISPR/Cas system in medaka
Ansai, S., & Kinoshita, M. (2014) · Biology Open · doi:10.1242/bio.20148177 · Cited by 227
Rapid characterization of CRISPR-Cas9 protospacer adjacent motif sequence elements
Karvelis, T., Gasiūnas, G., Young, J. K., Bigelyte, G., Šilanskas, A., Cigan, M., & Šikšnys, V. (2015) · Genome biology · doi:10.1186/s13059-015-0818-7 · Cited by 229
Genome editing in Ustilago maydis using the CRISPR–Cas system
Schuster, M., Schweizer, G., Reißmann, S., & Kahmann, R. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.09.001 · Cited by 231
Harnessing Type I and Type III CRISPR-Cas systems for genome editing
Li, Y., Pan, S., Zhang, Y., Ren, M., Feng, M., Peng, N., Chen, L., Liang, Y. X., & She, Q. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1044 · Cited by 222
Efficient Genome Editing in Clostridium cellulolyticum via CRISPR-Cas9 Nickase
Xu, T., Li, Y., Shi, Z. J., Hemme, C. L., Li, Y., Zhu, Y., Nostrand, J. D. V., He, Z., & Zhou, J. Z. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00873-15 · Cited by 231
A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death
Ma, H., Dang, Y., Wu, Y., Jia, G., Anaya, E., Zhang, J., Abraham, S., Choi, J.-G., Shi, G., Qi, L., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.049 · Cited by 223
Shi, S., Liang, Y., Zhang, M. M., Ang, E. L., & Zhao, H. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.10.011 · Cited by 219
CRISPR/Cas9 advances engineering of microbial cell factories
Jakočiūnas, T., Jensen, M. K., & Keasling, J. D. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.12.003 · Cited by 225
Advances in Industrial Biotechnology Using CRISPR-Cas Systems
Donohoue, P. D., Barrangou, R., & May, A. P. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.07.007 · Cited by 227
Deaminase-mediated multiplex genome editing in Escherichia coli
Banno, S., Nishida, K., Arazoe, T., Mitsunobu, H., & Kondo, A. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0102-6 · Cited by 213
Cas9 function and host genome sampling in Type II-A CRISPR–Cas adaptationPreprint
Wei, Y., Terns, R. M., & Terns, M. P. (2015) · Genes & Development · doi:10.1101/gad.257550.114 · Cited by 226
Multigene Knockout Utilizing Off-Target Mutations of the CRISPR/Cas9 System in Rice
Endo, M., Mikami, M., & Toki, S. (2014) · Plant and Cell Physiology · doi:10.1093/pcp/pcu154 · Cited by 216
Epigenetics and the regulation of stress vulnerability and resilience
Zannas, A. S., & West, A. E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.003 · Cited by 211
Charpentier, E., & Doudna, J. A. (2013) · Nature · doi:10.1038/495050a · Cited by 229
Development of potent in vivo mutagenesis plasmids with broad mutational spectra
Badran, A. H., & Liu, D. R. (2015) · Nature Communications · doi:10.1038/ncomms9425 · Cited by 211
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
Hou, P., Chen, S., Wang, S., Yu, X., Chen, Y. Z., Jiang, M., Zhuang, K., Ho, W., Hou, W., Huang, J. Y., et al. (2015) · Scientific Reports · doi:10.1038/srep15577 · Cited by 214
CRISPR-Cas12a-Assisted Recombineering in Bacteria
Yan, M., Yan, H., Ren, G., Zhao, J., Guo, X.-P., & Sun, Y. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.00947-17 · Cited by 211
Prediction of the sequence-specific cleavage activity of Cas9 variants
Kim, N., Kim, H. K., Lee, S., Seo, J. H., Choi, J. W., Park, J., Min, S., Yoon, S., Cho, S.-R., & Kim, H. H. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0537-9 · Cited by 198
Kang, Y. K., Kwon, K., Ryu, J. S., Lee, H. N., Park, C., & Chung, H. J. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00676 · Cited by 214
Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq
Kim, D., Kim, S., Kim, S., Park, J., & Kim, J.-S. (2016) · Genome Research · doi:10.1101/gr.199588.115 · Cited by 208
CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems
Jiang, W., & Marraffini, L. A. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104441 · Cited by 219
Marshall, R., Maxwell, C. S., Collins, S. P., Jacobsen, T., Luo, M. L., Begemann, M. B., Gray, B. N., January, E., Singer, A., He, Y., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.12.007 · Cited by 209
Reinvigorating natural product combinatorial biosynthesis with synthetic biology
Kim, E., Moore, B. S., & Yoon, Y. J. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1893 · Cited by 208
Michno, J., Wang, X., Liu, J., Curtin, S. J., Kono, T. J. Y., & Stupar, R. M. (2015) · GM crops & food · doi:10.1080/21645698.2015.1106063 · Cited by 213
Multiplex genome editing by natural transformation
Dalia, A. B., McDonough, E., & Camilli, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406478111 · Cited by 207
Automated multiplex genome-scale engineering in yeast
Si, T., Chao, R., Min, Y., Wu, Y., Ren, W., & Zhao, H. (2017) · Nature Communications · doi:10.1038/ncomms15187 · Cited by 200
Challenges in CRISPR/CAS9 delivery: potential roles of nonviral vectors
Li, L., He, Z.-Y., Wei, X.-W., Gao, G.-P., & Wei, Y.-Q. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.069 · Cited by 202
The CRISPR–Cas system for plant genome editing: advances and opportunities
Kumar, V. S., & Jain, M. (2014) · Journal of Experimental Botany · doi:10.1093/jxb/eru429 · Cited by 207
Boyle, E. A., Andreasson, J. O. L., Chircus, L. M., Sternberg, S. H., Wu, M. J., Guegler, C. K., Doudna, J. A., & Greenleaf, W. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700557114 · Cited by 205
Huang, H., Chai, C., Li, N., Rowe, P., Minton, N. P., Yang, S., Jiang, W., & Gu, Y. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00044 · Cited by 209
Development of a CRISPR-Cas9 Tool Kit for Comprehensive Engineering of Bacillus subtilis
Westbrook, A. W., Moo‐Young, M., & Chou, C.-H. P. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01159-16 · Cited by 205
Abadi, S., Yan, W. X., Amar, D., & Mayrose, I. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005807 · Cited by 208
Genetic Tools for the Industrially Promising Methanotroph Methylomicrobium buryatense
Puri, A. W., Owen, S., Chu, F., Chavkin, T., Beck, D. A. C., Kalyuzhnaya, M., & Lidstrom, M. E. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03795-14 · Cited by 196
Park, J. Y., Moon, B. Y., Park, J. W., Thornton, J. A., Park, Y. H., & Seo, K. S. (2017) · Scientific Reports · doi:10.1038/srep44929 · Cited by 195
High-Level dCas9 Expression Induces Abnormal Cell Morphology in Escherichia coli
Cho, S., Choe, D., Lee, E., Kim, S. C., Palsson, B. Ø., & Cho, B. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00462 · Cited by 195
CRISPy-web: An online resource to design sgRNAs for CRISPR applications
Blin, K., Pedersen, L. E., Weber, T., & Lee, S. Y. (2016) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2016.01.003 · Cited by 185
Progress and Prospects of CRISPR/Cas Systems in Insects and Other Arthropods
Sun, D., Guo, Z., Liu, Y., & Zhang, Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00608 · Cited by 199
Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity
Cromwell, C. R., Sung, K., Park, J., Krysler, A. R., Jovel, J., Kim, S. K., & Hubbard, B. P. (2018) · Nature Communications · doi:10.1038/s41467-018-03927-0 · Cited by 190
On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals
Mojica, F. J. M., & Montoliu, L. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.005 · Cited by 212
Harnessing CRISPR–Cas systems for bacterial genome editing
Selle, K., & Barrangou, R. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.008 · Cited by 187
Vrâncianu, C. O., Gheorghe, I., Barbu, I. C., & Chifiriuc, M. C. (2020) · Microorganisms · doi:10.3390/microorganisms8060935 · Cited by 202
Fujita, T., & Fujii, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.013 · Cited by 188
Recent advances in the heterologous expression of microbial natural product biosynthetic pathways
Ongley, S. E., Bian, X., Neilan, B. A., & Müller, R. (2013) · Natural Product Reports · doi:10.1039/c3np70034h · Cited by 189
Chen, B., Hu, J., Almeida, R., Liu, H., Balakrishnan, S., Covill‐Cooke, C., Lim, W. A., & Huang, B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1533 · Cited by 190
Engineering of high-precision base editors for site-specific single nucleotide replacement
Tan, J., Zhang, F., Karcher, D., & Bock, R. (2019) · Nature Communications · doi:10.1038/s41467-018-08034-8 · Cited by 198
An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9
Hynes, A. P., Rousseau, G. M., Lemay, M.-L., Horvath, P., Romero, D. A., Fremaux, C., & Moineau, S. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0004-7 · Cited by 185
CRISPR-Cas9 D10A Nickase-Assisted Genome Editing in Lactobacillus casei
Song, X., Huang, H., Xiong, Z., Ai, L., & Yang, S. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.01259-17 · Cited by 186
Carbon recovery by fermentation of CO-rich off gases – Turning steel mills into biorefineries
Molitor, B., Richter, H., Martin, M. E., Jensen, R. O., Juminaga, A., Mihalcea, C., & Angenent, L. T. (2016) · Bioresource Technology · doi:10.1016/j.biortech.2016.03.094 · Cited by 186
CRISPR-Cas systems for diagnosing infectious diseases
Kostyusheva, A., Brezgin, S., Babin, Y. Y., Vasilyeva, I., Glebe, D., Kostyushev, D. S., & Chulanov, V. (2021) · Methods · doi:10.1016/j.ymeth.2021.04.007 · Cited by 197
RNA-dependent RNA targeting by CRISPR-Cas9
Strutt, S. C., Torrez, R. M., Kaya, E., Negrete, O. A., & Doudna, J. A. (2018) · eLife · doi:10.7554/elife.32724 · Cited by 186
Multiplex gene editing of the Yarrowia lipolytica genome using the CRISPR-Cas9 system
Gao, S., Tong, Y., Wen, Z., Zhu, L., Ge, M., Chen, D., Jiang, Y., & Yang, S. (2016) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-016-1789-8 · Cited by 187
Synthetic microbial consortia for biosynthesis and biodegradation: promises and challenges
Che, S., & Men, Y. (2019) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-019-02211-4 · Cited by 177
Experimental Design, Population Dynamics, and Diversity in Microbial Experimental Evolution
den Bergh, B. V., Swings, T., Fauvart, M., & Michiels, J. J. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00008-18 · Cited by 200
Rapid and Efficient One-Step Metabolic Pathway Integration in E. coli
Bassalo, M. C., Garst, A. D., Halweg‐Edwards, A. L., Grau, W. C., Domaille, D. W., Mutalik, V. K., Arkin, A. P., & Gill, R. T. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00187 · Cited by 179
Deciphering, Communicating, and Engineering the CRISPR PAM
Leenay, R. T., & Beisel, C. L. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.11.024 · Cited by 180
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages
Martel, B., & Moineau, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku628 · Cited by 182
Li, Y., Zhang, J., Chen, D., Yang, P., Jiang, F., Wang, X., & Kang, L. (2016) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2016.10.003 · Cited by 178
Pyne, M. E., Bruder, M. R., Moo‐Young, M., Chung, D. A., & Chou, C.-H. P. (2016) · Scientific Reports · doi:10.1038/srep25666 · Cited by 187
The DarTG toxin-antitoxin system provides phage defense by ADP-ribosylating viral DNA
LeRoux, M., Srikant, S., Teodoro, G. I. C., Zhang, T., Littlehale, M. L., Doron, S., Badiee, M., Leung, A. K. L., Sorek, R., & Laub, M. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01153-5 · Cited by 123
Targeted DNA degradation using a CRISPR device stably carried in the host genome
Caliando, B. J., & Voigt, C. A. (2015) · Nature Communications · doi:10.1038/ncomms7989 · Cited by 172
Conjugative Delivery of CRISPR-Cas9 for the Selective Depletion of Antibiotic-Resistant Enterococci
Rodrigues, M., McBride, S. W., Hullahalli, K., Palmer, K. L., & Duerkop, B. A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-19 · Cited by 173
Wang, Y., Zhang, Z.-T., Seo, S.-O., Patrick, L., Lu, T., Jin, Y., & Blaschek, H. P. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00060 · Cited by 179
Defining synonymous codon compression schemes by genome recoding
Wang, K., Fredens, J., Brunner, S. F., Kim, S. H., Chia, T., & Chin, J. W. (2016) · Nature · doi:10.1038/nature20124 · Cited by 170
Lam, K. N., Spanogiannopoulos, P., Soto-Perez, P., Alexander, M., Nalley, M. J., Bisanz, J. E., Nayak, R. R., Weakley, A. M., Yu, F. B., & Turnbaugh, P. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109930 · Cited by 176
Xia, Y., Chu, W., Qi, Q., & Xun, L. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1189 · Cited by 171
TALEN or Cas9 – Rapid, Efficient and Specific Choices for Genome Modifications
Wei, C., Liu, J., Yu, Z., Zhang, B., Gao, G., & Jiao, R. (2013) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2013.03.013 · Cited by 171
Baltz, R. H. (2015) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-015-1682-x · Cited by 169
Bober, J. R., Beisel, C. L., & Nair, N. U. (2018) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121019 · Cited by 184
Applications of CRISPR/Cas System to Bacterial Metabolic Engineering
Cho, S., Shin, J., & Cho, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041089 · Cited by 180
Li, Q., Chen, J., Minton, N. P., Zhang, Y., Wen, Z., Liu, J., Yang, H., Zeng, Z., Ren, X., Yang, J., et al. (2016) · Biotechnology Journal · doi:10.1002/biot.201600053 · Cited by 172
Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management
Dinić, S., Јovanović, J. A., Uskoković, A. S., Mihailović, M., Grdović, N., Tolić, A., Rajić, J., Đorđević, M., & Vidaković, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1006376 · Cited by 196
Programmable RNA-Guided RNA Effector Proteins Built from Human Parts
Rauch, S., He, E., Srienc, M., Zhou, H., Zhang, Z. S., & Dickinson, B. C. (2019) · Cell · doi:10.1016/j.cell.2019.05.049 · Cited by 163
Dogma Derailed: The Many Influences of RNA on the Genome
Sabin, L. R., Delàs, M. J., & Hannon, G. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.010 · Cited by 172
Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference
Barrangou, R., Birmingham, A., Wiemann, S., Beijersbergen, R. L., Hornung, V., & Smith, A. V. B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv226 · Cited by 173
Mitigating amphibian chytridiomycoses in nature
Garner, T. W. J., Schmidt, B. R., Martel, A., Pasmans, F., Muths, E., Cunningham, A. A., Weldon, C., Fisher, M. C., & Bosch, J. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0207 · Cited by 162
Suh, S., Choi, E. H., Leinonen, H., Foik, A. T., Newby, G. A., Yeh, W.-H., Dong, Z., Kiser, P. D., Lyon, D. C., Liu, D. R., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00632-6 · Cited by 169
Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons
Yoshimizu, T., Pan, J. Q., Mungenast, A. E., Madison, J. M., Su, S. C., Ketterman, J., Öngür, D., McPhie, D. L., Cohen, B. M., Perlis, R. H., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.143 · Cited by 161
How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance
Gholizadeh, P., Köse, Ş., Dao, S., Ganbarov, K., Tanomand, A., Dal, T., Aghazadeh, M. H., Ghotaslou, R., Rezaee, M. A., Yousefi, B., et al. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s247271 · Cited by 172
CRISPR Immunological Memory Requires a Host Factor for Specificity
Nuñez, J. K., Bai, L., Harrington, L. B., Hinder, T. L., & Doudna, J. A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.027 · Cited by 159
Metadata
- Authors
- Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A.
- Affiliations
- Rockefeller University (US)
- Broad Institute (US)
- Corresponding author
- Bikard, David
- Marraffini, Luciano A
- Venue
- Nature Biotechnology
- Published
- 2013-01-29
- Volume
- 31
- Issue
- 3
- Pages
- 233-239
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3748948
- OpenAlex
- W2000046950
- Cited by
- 2,429
- References
- 51
- Citations by year
- 2026: 84 · 2025: 124 · 2024: 151 · 2023: 162 · 2022: 199 · 2021: 203 · 2020: 245 · 2019: 185 · 2018: 206 · 2017: 208 · 2016: 203 · 2015: 174 · 2014: 183 · 2013: 98
- FWCI
- 98.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- U.S. Public Health Service
- National Institute of Mental Health (DP1MH100706)
- National Institute of General Medical Sciences (T32GM007753)
- National Institute of Allergy and Infectious Diseases (DP2AI104556)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, bacterial genome editing, Streptococcus pneumoniae, Escherichia coli, targeted mutagenesis, recombineering, genome editing
- MeSH terms
- Base Sequence, Endonucleases, Escherichia coli, Genetic Engineering, Molecular Sequence Data, Streptococcus pneumoniae, Mutagenesis, Site-Directed, Genome, Bacterial, DNA Cleavage, RNA, Small Untranslated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
